Laura Pala has a BSc in Chemistry from the University of Cagliari (Italy) and a MSc in Inorganic Chemistry from the University of Pisa (Italy), involving a year-long research project at the University of Strathclyde (UK), in Prof. Duncan Graham's lab. Here, she synthesised and functionalised silver nanoparticles for pathogenic DNA detection, using SERS. She then obtained her PhD in Organic Medicinal Chemistry at the University of Glasgow (UK) under Prof. Richard Hartley's supervision, in collaboration with Prof. Mike Murphy's group at the University of Cambridge (UK). Her doctoral work focused on the synthesis and in vitro testing of small molecules as prodrugs or reactive oxygen species detectors, targeting mitochondria during ischaemia/reperfusion injury and other inflammatory diseases. She then moved to Biosynth Carbosynth, where she worked as Product Manager in the Marketing department for a year. She is currently working as Business Development Scientist at Oxford HighQ.
Laura Pala has a BSc in Chemistry from the University of Cagliari (Italy) and a MSc in Inorganic Chemistry from the University of Pisa (Italy), involving a year-long research project at the University of Strathclyde (UK), in Prof. Duncan Graham's lab. Here, she synthesised and functionalised silver nanoparticles for pathogenic DNA detection, using SERS. She then obtained her PhD in Organic Medicinal Chemistry at the University of Glasgow (UK) under Prof. Richard Hartley's supervision, in collaboration with Prof. Mike Murphy's group at the University of Cambridge (UK). Her doctoral work focused on the synthesis and in vitro testing of small molecules as prodrugs or reactive oxygen species detectors, targeting mitochondria during ischaemia/reperfusion injury and other inflammatory diseases. She then moved to Biosynth Carbosynth, where she worked as Product Manager in the Marketing department for a year. She is currently working as Business Development Scientist at Oxford HighQ.